5.2 Patient-level interventions
Antimicrobial prescription needs to be monitored at the level of each individual patient for the benefit of that patient, and to reduce the selection pressure that leads to the development of resistance.
Figure 3 shows the sequence of decisions that may be needed at the level of patient treatment.

Choosing the correct drug for empirical treatment depends on clinical assessment and the local antimicrobial susceptibility data. Once culture and antimicrobial susceptibility test results are available for an individual patient, the antimicrobial with the narrowest spectrum of activity should be used as a treatment. If no organism is cultured from the samples, clinical reassessment determines the course of action.
Choosing the best strategy
